PLA2G7 and lymphoma: Since no associations between plaque formation, arterial wall thickening or cardiovascular contributors was detected, we assume that the increased Lp-PLA2 activity observed in SS patients with lymphoma are not influenced by underlying subclinical cardiovascular disease.